<DOC>
	<DOCNO>NCT00290823</DOCNO>
	<brief_summary>The purpose study determine whether short course increase corticosteroid dosing taper dose decrease seizure frequency compare standard corticosteroid dose patient neurocysticercosis ( NCC ) .</brief_summary>
	<brief_title>Corticosteroids Reduce Frequency Seizures Neurocysticercosis Patients</brief_title>
	<detailed_description>NCC common parasitic infection central nervous system ( CNS ) . It cause ingestion egg tapeworm genus Taenia . Inflammation , seizures , neurologic problem may occur patient NCC . Corticosteroids current standard care NCC patient , corticosteroid many side effect . Albendazole use treat infection cause worm ; however , unclear use corticosteroid dexamethasone decrease seizure frequency NCC patient . The purpose study evaluate efficacy reduce seizure frequency short course dexamethasone taper dose give albendazole , compare standard dexamethasone albendazole treatment , NCC patient . In open label study , patient randomly assign one two arm . Group I receive 6 mg dexamethasone daily 10 day . Group II receive 6 mg dexamethasone daily 10 day , 8 mg dexamethasone daily 4 week 2-week taper . Both group also receive albendazole omeprazole ( medicine help prevent gastroesophageal disease [ GERD ] , side effect corticosteroid use ) . There 13 study visit 360-day period . Blood collection occur visit . Group II also undergo sputum smear rapid culture test Days 14 , 28 , 42 . Patients undergo magnetic resonance imaging ( MRI ) screen Day 180 compute tomography ( CT ) scan Day 360 .</detailed_description>
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Neurocysticercosis</mesh_term>
	<mesh_term>Cysticercosis</mesh_term>
	<mesh_term>Taeniasis</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Albendazole</mesh_term>
	<criteria>Diagnosed intraparenchymal NCC 20 few active cyst , confirm enzymelinked immunoelectrotransfer blot ( EITB ) Diagnosed epilepsy secondary NCC , history one spontaneous seizure within 6 month prior study entry Willingness hospitalize minimum 2 week study PPD negative OR negative smear tuberculosis ( TB ) PPD positive Willing use acceptable form contraception study least 1 month albendazole therapy Primary generalize seizure cause NCC Subarachnoid ventricular NCC Any vesicular lesion great 2 cm diameter Previous therapy albendazole praziquantel within 2 year study entry . Patients previously receive singledose albendazole intestinal parasite exclude . Intracranial hypertension , confirm CT MRI History status epilepticus Focal neurological defect Unstable consistently abnormal vital sign ( e.g. , body temperature , pulse , respiratory rate , blood pressure ) Cysts critical region , include brainstem eye Pulmonary TB History TB patient history TB close contact patient Chest xray suggestive past current TB Diabetes Systemic condition ( e.g. , chronic kidney failure , liver disease , heart failure , steroiddependent immune disease ) NCC may interfere study Predicted survival time le 1 year Inability undergo CT MRI Hypersensitivity albendazole , antiepileptic drug , contrast Hypertension rest Require corticosteroid , receive corticosteroid 4 week prior study entry , receive corticosteroid 9 day within 6 month prior study entry Other CNS process may interfere study assessment Pregnancy breastfeed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Taenia</keyword>
	<keyword>Seizures</keyword>
	<keyword>Tapeworm</keyword>
	<keyword>Parasite</keyword>
</DOC>